Versant Capital Management »

Caris Life Sciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $31k 1.8k 17.88
2025-12-31 $3.9k 146 26.98

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Avago Technologies Stock (AVGO)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Vanguard Total Stk Mkt Etf (VTI)
State Street Spdr S&p Global Natural Resources Etf Etf (GNR)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)

View all positions for Versant Capital Management

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
J. H. Whitney Equity Partners VI
FMR
Coatue Management
T. Rowe Price Investment Management
Braidwell
PointState Capital
BlackRock
Neuberger Berman Group
Vanguard Portfolio Management
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences